(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.15%) $82.51
(1.33%) $2.06
(-0.53%) $2 345.20
(-1.10%) $27.36
(-0.06%) $960.90
(0.18%) $0.934
(0.31%) $11.02
(0.11%) $0.797
(0.01%) $93.31
2.11% $ 10.16
@ $15.41
Wydano: 14 vas. 2024 @ 18:19
Zwrot: -34.07%
Poprzedni sygnał: vas. 14 - 16:30
Poprzedni sygnał:
Zwrot: -3.51 %
Live Chart Being Loaded With Signals
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers...
Stats | |
---|---|
Dzisiejszy wolumen | 332 566 |
Średni wolumen | 831 451 |
Kapitalizacja rynkowa | 568.09M |
EPS | $0 ( 2024-03-14 ) |
Następna data zysków | ( $-0.530 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.75 |
ATR14 | $0.0190 (0.19%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Harmon Cyrus | Sell | 20 000 | Common Stock |
2024-03-18 | Zojwalla Naseem | Sell | 13 700 | Stock Option (Right to Buy) |
2024-03-18 | Zojwalla Naseem | Buy | 13 700 | Common Stock |
2024-03-05 | Rappaport Andrew | Buy | 385 965 | Common Stock |
2024-03-05 | Rappaport Andrew | Sell | 481 014 | Common Stock |
INSIDER POWER |
---|
66.24 |
Last 96 transactions |
Buy: 6 282 820 | Sell: 988 788 |
Wolumen Korelacja
Olema Pharmaceuticals, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Olema Pharmaceuticals, Korelacja - Waluta/Towar
Olema Pharmaceuticals, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-377 000 (0.00 %) |
EPS: | $-2.14 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-377 000 (0.00 %) |
EPS: | $-2.14 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.66M (0.00 %) |
EPS: | $-2.56 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.795 |
Financial Reports:
No articles found.
Olema Pharmaceuticals,
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej